NCT01705184
Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer. treatment 2 completed NCT02019979
Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) treatment 2 terminated NCT03380871
A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer treatment 1 completed NCT01814163
Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab Not Available Not Available completed NCT02679443
Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy No drug interventions prevention Not Available completed NCT02831933
Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma treatment 2 terminated NCT02852798
Apatinib Combined With Docetaxel Monotherapy as Second-line Therapy of Advanced EGFR WT, Non-squamous NSCLC Not Available Not Available unknown_status NCT05764928
Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy No drug interventions treatment 1 / 2 not_yet_recruiting NCT01373463
Cisplatin and Pemetrexed With Radiation Followed by Lobectomy treatment 1 terminated NCT02259582
A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer treatment 2 completed NCT01161173
An Observational Study of Tarceva (Erlotinib) in Routine Daily Clinical Practice as Second Line Treatment in Patients With Non-small Cell Lung Cancer Not Available Not Available completed NCT02049060
Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin treatment 1 / 2 completed NCT03846310
A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer treatment 1 active_not_recruiting NCT01473563
A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Not Available 2 completed NCT05853887
Liquid Biopsy Based NGS in Newly Diagnosed NSCLC No drug interventions health_services_research Not Available recruiting NCT03177291
Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC treatment 1 active_not_recruiting NCT03779191
Alectinib in Combination With Bevacizumab in ALK Positive NSCLC treatment 2 completed NCT04698681
NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial No drug interventions Not Available Not Available terminated NCT04265534
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC treatment 2 terminated NCT03912389
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC treatment 3 unknown_status NCT01303926
Quality of Life Comparison in Advanced Non-squamous Non Small Cell Lung Cancer treatment 3 unknown_status